Searching map area
Lillian Siu
? TBD
Canadian oncologist and physician-scientist
Nobody has rated this yet. Be the first!
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands
article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
scientific article
Abstract 3161: Identification of HPV/p16-associated microRNAs in primary oropharyngeal carcinoma
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
article
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma
scientific article published on 15 July 2010
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas
scientific article published on 9 February 2015
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
scientific article
Magnetic resonance imaging of nasopharyngeal carcinoma
article
Tumour heterogeneity in the clinic
scientific article
Abstract CT190: A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR)
scholarly article
Lists 0

Lillian Lai Yun Siu is a Canadian oncologist and physician-scientist who researches anticancer drug development. She is a professor of medicine at the University of Toronto and a senior medical oncologist at the Princess Margaret Cancer Centre.

Elsewhere
Instance of
Occupation
References